Subscribe to RSS
DOI: 10.1055/s-2005-864095
© Georg Thieme Verlag KG Stuttgart · New York
Induction of Apoptosis by Apicularen A in Human Promyelocytic Leukemia Cell Line HL-60
Publication History
Received: May 30, 2004
Accepted: October 8, 2004
Publication Date:
27 April 2005 (online)
Abstract
Apicularen A, a macrolide isolated from the myxobacterial genus Chondromyces, suppressed the proliferation of human promyelocytic leukemia cells (HL-60 cells), increased the release of lactate dehydrogenase and induced condensation and fragmentation of chromatin at 1 to 100 nM. In addition, it induced the DNA fragmentation, increased the percentage of annexin V-stained cells, and cleaved poly(ADP-ribose) polymerase (PARP), a substrate of caspase. In contrast, apicularen B, an N-acetylglucosamine glycoside of apicularen A, had no such effects at 100 nM. These findings indicated that apicularen A induces apoptosis in HL-60 cells by activating caspases. Phosphorylation of p44/42 MAPK, p38 MAPK and Akt was not induced by apicularen A at 100 nM, suggesting that the apicularen A-induced apoptosis in HL-60 cells is not regulated by the activation of p44/42 MAPK, p38 MAPK or Akt. Furthermore, by acridine orange staining of the cells, it was suggested that apicularen A but not apicularen B inhibits vacuolar-type H+-ATPase.
Key words
Apicularen A - apicularen B - Chondromyces - Polyangiaceae - Myxobacteriales - apoptosis - HL-60 cells - V-ATPase
References
- 1 Kunze B, Jansen R, Sasse F, Höfle G, Reichenbach H. Apicularens A and B, new cytostatic macrolides from Chondromyces species (myxobacteria): production, physico-chemical and biological properties. J Antibiotics. 1998; 51 1075-80
- 2 Mesner P W, Budihardjo I, Kaufmann S H. Chemotherapy-induced apoptosis. Adv Pharmacol. 1997; 41 461-99
- 3 Hong J J, Yamaki K, Ishihara K, Ahn J W, Zee O P, Ohuchi K. Induction of apoptosis of RAW 264.7 cells by the cytostatic macrolide apicularen A. J Pharm Pharmacol. 2003; 55 1299-306
- 4 Roulston A, Reinhard C, Amiri P, Williams L T. Early activation of c-Jun N-terminal kinase and p38 kinase regulates cell survival in response to tumor necrosis factor α. J Biol Chem. 1998; 273 10 232-9
- 5 Chin B Y, Petrache I, Choi A H, Choi M E. Transforming growth factor β1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages. J Biol Chem. 1999; 274 11 362-8
- 6 Jun C D, Oh C D, Kwak H J, Pae H O, Yoo J C, Choi B M. et al . Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. J Immunol. 1999; 162 3395-401
- 7 Koh J S, Lieberthal W, Heydrick S, Levine J S. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway. J Clin Invest. 1998; 102 716-27
- 8 Jansen R, Kunze B, Reichenbach H, Höfle G. Apicularen A and B, cytotoxic 10-membered lactones with a novel mechanism of action from Chondromyces species (myxobacteria): Isolation, structure elucidation, and biosynthesis. Eur J Org Chem 2000: 913-9
- 9 Yoshimoto Y, Imoto M. Induction of EGF-dependent apoptosis by vacuolar-type H+-ATPase inhibitors in A431 cells overexpressing the EGF receptor. Exp Cell Res. 2002; 279 118-27
- 10 Messmer U K, Briner V A, Pfeilschifter J. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int. 1999; 55 2322-37
- 11 Brunet A, Datta S R, Greenberg M E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol. 2001; 11 297-305
- 12 Boyd M R, Farina C, Belfiore P, Gagliardi S, Kim J W, Hayakawa Y. et al . Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-ATPase. J Pharm Exp Ther. 2001; 297 114-20
- 13 Bowman E J, Siebers A, Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA. 1988; 85 7972-6
- 14 Dröse S, Bindseil K U, Bowman E J, Siebers A, Zeeck A, Altendorf K. Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosine-triphosphatases. Biochemistry. 1993; 32 3902-6
- 15 Ohta T, Arakawa H, Futagami F, Fushida S, Kitagawa H, Kayahara M. et al . Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1. J Pathol. 1998; 185 324-30
- 16 Ishisaki A, Hashimoto S, Amagasa T, Nishihara T. Caspase-3 activation during the process of apoptosis induced by a vacuolar type H+-ATPase inhibitor. Biol Cell. 1999; 91 507-13
- 17 Geisow M J, Beaven G H, Hart P D, Young M R. Site of action of a polyanion inhibitor of phagosome-lysosome fusion in cultured macrophages. Exp Cell Res. 1980; 126 159-65
- 18 Moriyama Y, Nelson N. Lysosomal H+-translocating ATPase has a similar subunit structure to chromaffin granule H+-ATPase complex. Biochim Biophys Acta. 1989; 980 241-7
- 19 Yoshimori T, Yamamoto A, Noriyama Y, Futai M, Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H+-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem. 1991; 266 17 707-12
- 20 Ishisaka A, Hashimoto S, Amagasa T, Nishihara T. Caspase-3 activation during the process of apoptosis induced by a vacuolar type H+-ATPase inhibitor. Biol Cell. 1999; 91 507-13
Prof. Dr. Kazuo Ohuchi
Laboratory of Pathophysiological Biochemistry
Graduate School of Pharmaceutical Sciences
Tohoku University
Aoba Aramaki
Aoba-ku
Sendai
Miyagi 980-8578
Japan
Phone: +81-22-217-6860
Fax: +81-22-217-6859
Email: ohuchi-k@mail.pharm.tohoku.ac.jp